2021-2030 Report on Global Parkinson Disease Drug Market by Player, Region, Type, Applica...

  • Report ID:95578
  • Industry Name: Medical Devices & Consumables
  • Publishing Date: July-2021
  • No. of Pages: 117
                              
This report studies the Parkinson Disease Drug market, covering market size for segment by type (Sinemet-CR, Trastal, etc.), by application (Under 40 Years Old, 40-65 Years Old, etc.), by Sales Channel (Direct Channel, Distribution Channel), by player (Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Parkinson Disease Drug from 2015-2020, and provides extensive market forecasts from 2021-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Parkinson Disease Drug market. Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover. This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period. The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. Leading players of Parkinson Disease Drug including: Merck Akorn GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie Kyowa Hakko Kirin Pharma Astellas Pharma Desitin Arzneimittel Endo Pharmaceuticals F.Hoffmann-La Roche H.Lundbeck Valeant Apokyn Orion Stada Arzneimittel US WorldMeds Valeant Pharmaceuticals Market split by Type, can be divided into: Sinemet-CR Trastal Madopar COMT Inhibitor Other Market split by Application, can be divided into: Under 40 Years Old 40-65 Years Old Above 65 Years Old Market split by Sales Channel, can be divided into: Direct Channel Distribution Channel Market segment by Region/Country including: North America (United States, Canada and Mexico) Europe (Germany, UK, France, Italy, Russia and Spain etc.) Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) South America (Brazil, Argentina and Colombia etc.) Middle East & Africa (South Africa, UAE and Saudi Arabia etc.) If you have any special requirements, please let us know and we can provide you the customized report as you want.
                        
Table of Contents Chapter 1 Parkinson Disease Drug Market Overview 1.1 Parkinson Disease Drug Definition 1.2 Global Parkinson Disease Drug Market Size Status and Outlook (2015-2030) 1.3 Global Parkinson Disease Drug Market Size Comparison by Region (2015-2030) 1.4 Global Parkinson Disease Drug Market Size Comparison by Type (2015-2030) 1.5 Global Parkinson Disease Drug Market Size Comparison by Application (2015-2030) 1.6 Global Parkinson Disease Drug Market Size Comparison by Sales Channel (2015-2030) 1.7 Parkinson Disease Drug Market Dynamics (COVID-19 Impacts) 1.7.1 Market Drivers/Opportunities 1.7.2 Market Challenges/Risks 1.7.3 Market News (Mergers/Acquisitions/Expansion) 1.7.4 COVID-19 Impacts on Current Market 1.7.5 Post-Strategies of COVID-19 Outbreak Chapter 2 Parkinson Disease Drug Market Segment Analysis by Player 2.1 Global Parkinson Disease Drug Sales and Market Share by Player (2018-2020) 2.2 Global Parkinson Disease Drug Revenue and Market Share by Player (2018-2020) 2.3 Global Parkinson Disease Drug Average Price by Player (2018-2020) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player Chapter 3 Parkinson Disease Drug Market Segment Analysis by Type 3.1 Global Parkinson Disease Drug Market by Type 3.1.1 Sinemet-CR 3.1.2 Trastal 3.1.3 Madopar 3.1.4 COMT Inhibitor 3.1.5 Other 3.2 Global Parkinson Disease Drug Sales and Market Share by Type (2015-2020) 3.3 Global Parkinson Disease Drug Revenue and Market Share by Type (2015-2020) 3.4 Global Parkinson Disease Drug Average Price by Type (2015-2020) 3.5 Leading Players of Parkinson Disease Drug by Type in 2020 3.6 Conclusion of Segment by Type Chapter 4 Parkinson Disease Drug Market Segment Analysis by Application 4.1 Global Parkinson Disease Drug Market by Application 4.1.1 Under 40 Years Old 4.1.2 40-65 Years Old 4.1.3 Above 65 Years Old 4.2 Global Parkinson Disease Drug Revenue and Market Share by Application (2015-2020) 4.3 Leading Consumers of Parkinson Disease Drug by Application in 2020 4.4 Conclusion of Segment by Application Chapter 5 Parkinson Disease Drug Market Segment Analysis by Sales Channel 5.1 Global Parkinson Disease Drug Market by Sales Channel 5.1.1 Direct Channel 5.1.2 Distribution Channel 5.2 Global Parkinson Disease Drug Revenue and Market Share by Sales Channel (2015-2020) 5.3 Leading Distributors/Dealers of Parkinson Disease Drug by Sales Channel in 2020 5.4 Conclusion of Segment by Sales Channel Chapter 6 Parkinson Disease Drug Market Segment Analysis by Region 6.1 Global Parkinson Disease Drug Market Size and CAGR by Region (2015-2030) 6.2 Global Parkinson Disease Drug Sales and Market Share by Region (2015-2020) 6.3 Global Parkinson Disease Drug Revenue and Market Share by Region (2015-2020) 6.4 North America 6.4.1 North America Market by Country 6.4.2 North America Parkinson Disease Drug Market Share by Type 6.4.3 North America Parkinson Disease Drug Market Share by Application 6.4.4 United States 6.4.5 Canada 6.4.6 Mexico 6.5 Europe 6.5.1 Europe Market by Country 6.5.2 Europe Parkinson Disease Drug Market Share by Type 6.5.3 Europe Parkinson Disease Drug Market Share by Application 6.5.4 Germany 6.5.5 UK 6.5.6 France 6.5.7 Italy 6.5.8 Russia 6.5.9 Spain 6.6 Asia-Pacific 6.6.1 Asia-Pacific Market by Country 6.6.2 Asia-Pacific Parkinson Disease Drug Market Share by Type 6.6.3 Asia-Pacific Parkinson Disease Drug Market Share by Application 6.6.4 China 6.6.5 Japan 6.6.6 Korea 6.6.7 India 6.6.8 Southeast Asia 6.6.9 Australia 6.7 South America 6.7.1 South America Market by Country 6.7.2 South America Parkinson Disease Drug Market Share by Type 6.7.3 South America Parkinson Disease Drug Market Share by Application 6.7.4 Brazil 6.7.5 Argentina 6.7.6 Colombia 6.8 Middle East & Africa 6.8.1 Middle East & Africa Market by Country 6.8.2 Middle East & Africa Parkinson Disease Drug Market Share by Type 6.8.3 Middle East & Africa Parkinson Disease Drug Market Share by Application 6.8.4 UAE 6.8.5 Saudi Arabia 6.8.6 South Africa 6.9 Conclusion of Segment by Region Chapter 7 Profile of Leading Parkinson Disease Drug Players 7.1 Merck 7.1.1 Company Snapshot 7.1.2 Product/Service Offered 7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share) 7.1.4 COVID-19 Impact on Merck 7.2 Akorn 7.3 GSK 7.4 Novartis 7.5 Boehringer Ingelheim 7.6 Teva Pharmaceutical 7.7 Abbvie 7.8 Kyowa Hakko Kirin Pharma 7.9 Astellas Pharma 7.10 Desitin Arzneimittel 7.11 Endo Pharmaceuticals 7.12 F.Hoffmann-La Roche 7.13 H.Lundbeck 7.14 Valeant 7.15 Apokyn 7.16 Orion 7.17 Stada Arzneimittel 7.18 US WorldMeds 7.19 Valeant Pharmaceuticals Chapter 8 Upstream and Downstream Analysis of Parkinson Disease Drug 8.1 Industrial Chain of Parkinson Disease Drug 8.2 Upstream of Parkinson Disease Drug 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.2.4 Manufacturing Cost Structure 8.2.5 Manufacturing Process 8.3 Downstream of Parkinson Disease Drug 8.3.1 Leading Distributors/Dealers of Parkinson Disease Drug 8.3.2 Leading Consumers of Parkinson Disease Drug Chapter 9 Development Trend of Parkinson Disease Drug (2021-2030) 9.1 Global Parkinson Disease Drug Market Size (Sales and Revenue) Forecast (2021-2030) 9.2 Global Parkinson Disease Drug Market Size and CAGR Forecast by Region (2021-2030) 9.3 Global Parkinson Disease Drug Market Size and CAGR Forecast by Type (2021-2030) 9.4 Global Parkinson Disease Drug Market Size and CAGR Forecast by Application (2021-2030) 9.5 Global Parkinson Disease Drug Market Size and CAGR Forecast by Sales Channel (2021-2030) Chapter 10 Appendix 10.1 Research Methodology 10.2 Data Sources 10.3 Disclaimer 10.4 Analysts Certification
                
List of Tables and Figures Figure Parkinson Disease Drug Example Figure Global Parkinson Disease Drug Revenue (Million $) Status and Outlook (2015-2030) Figure Global Parkinson Disease Drug Revenue (Million $) Comparison by Region (2015-2030) Figure Global Parkinson Disease Drug Revenue (Million $) Comparison by Type (2015-2030) Figure Global Parkinson Disease Drug Revenue (Million $) Comparison by Application (2015-2030) Figure Global Parkinson Disease Drug Revenue (Million $) Comparison by Sales Channel (2015-2030) Table Global Parkinson Disease Drug Sales by Player (2018-2020) Table Global Parkinson Disease Drug Sales Market Share by Player (2018-2020) Figure Global Parkinson Disease Drug Sales Market Share by Player in 2020 Table Global Parkinson Disease Drug Revenue (Million $) by Player (2018-2020) Table Global Parkinson Disease Drug Revenue Market Share by Player (2018-2020) Figure Global Parkinson Disease Drug Revenue Market Share by Player in 2020 Table Global Parkinson Disease Drug Average Price by Player (2018-2020) Figure Global Parkinson Disease Drug Average Price by Player in 2020 Figure Global Parkinson Disease Drug Players Competition Situation – Top 5 Players’ Revenue Market Share in 2018 Figure Global Parkinson Disease Drug Players Competition Trends – Top 5 Players’ Revenue Market Share in 2020 Figure Example of Sinemet-CR Figure Global Sinemet-CR Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Trastal Figure Global Trastal Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Madopar Figure Global Madopar Revenue (Million $) and Growth Rate (2015-2020) Figure Example of COMT Inhibitor Figure Global COMT Inhibitor Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Other Figure Global Other Revenue (Million $) and Growth Rate (2015-2020) Table Global Parkinson Disease Drug Sales by Type (2015-2020) Table Global Parkinson Disease Drug Sales Market Share by Type (2015-2020) Figure Global Parkinson Disease Drug Sales Market Share by Type in 2020 Table Global Parkinson Disease Drug Revenue (Million $) by Type (2015-2020) Table Global Parkinson Disease Drug Revenue Market Share by Type (2015-2020) Figure Global Parkinson Disease Drug Revenue Market Share by Type in 2020 Table Global Parkinson Disease Drug Average Price by Type (2015-2020) Figure Global Parkinson Disease Drug Average Price by Type in 2020 Table Leading Players of Parkinson Disease Drug by Type in 2020 Figure Example of Under 40 Years Old Figure Global Parkinson Disease Drug for Under 40 Years Old Revenue (Million $) and Growth Rate (2015-2020) Figure Example of 40-65 Years Old Figure Global Parkinson Disease Drug for 40-65 Years Old Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Above 65 Years Old Figure Global Parkinson Disease Drug for Above 65 Years Old Revenue (Million $) and Growth Rate (2015-2020) Table Global Parkinson Disease Drug Sales by Application (2015-2020) Table Global Parkinson Disease Drug Sales Market Share by Application (2015-2020) Figure Global Parkinson Disease Drug Sales Market Share by Application in 2020 Table Leading Consumers of Parkinson Disease Drug by Application in 2020 Figure Example of Direct Channel Figure Global Parkinson Disease Drug for Direct Channel Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Distribution Channel Figure Global Parkinson Disease Drug for Distribution Channel Revenue (Million $) and Growth Rate (2015-2020) Table Global Parkinson Disease Drug Revenue by Sales Channel (2015-2020) Table Global Parkinson Disease Drug Revenue Market Share by Sales Channel (2015-2020) Figure Global Parkinson Disease Drug Revenue Market Share by Sales Channel in 2020 Table Leading Distributors/Dealers of Parkinson Disease Drug by Sales Channel in 2020 Table Global Parkinson Disease Drug Market Size and CAGR by Region (2015-2030) Table Global Parkinson Disease Drug Sales by Region (2015-2020) Table Global Parkinson Disease Drug Sales Market Share by Region (2015-2020) Figure Global Parkinson Disease Drug Sales Market Share by Region in 2020 Table Global Parkinson Disease Drug Revenue (Million $) by Region (2015-2020) Table Global Parkinson Disease Drug Revenue Market Share by Region (2015-2020) Figure Global Parkinson Disease Drug Revenue Market Share by Region in 2020 Table North America Parkinson Disease Drug Sales by Country (2015-2020) Figure North America Parkinson Disease Drug Sales Market Share by Country (2015-2020) Table North America Parkinson Disease Drug Revenue by Country (2015-2020) Figure North America Parkinson Disease Drug Revenue Market Share by Country (2015-2020) Figure North America Parkinson Disease Drug Market Share by Type in 2020 Figure North America Parkinson Disease Drug Market Share by Application in 2020 Figure United States Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure United States Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Figure Canada Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure Canada Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Figure Mexico Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure Mexico Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Table Europe Parkinson Disease Drug Sales by Country (2015-2020) Figure Europe Parkinson Disease Drug Sales Market Share by Country (2015-2020) Table Europe Parkinson Disease Drug Revenue by Country (2015-2020) Figure Europe Parkinson Disease Drug Revenue Market Share by Country (2015-2020) Figure Europe Parkinson Disease Drug Market Share by Type in 2020 Figure Europe Parkinson Disease Drug Market Share by Application in 2020 Figure Germany Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure Germany Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Figure UK Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure UK Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Figure France Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure France Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Figure Italy Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure Italy Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Figure Russia Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure Russia Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Figure Spain Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure Spain Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Table Asia-Pacific Parkinson Disease Drug Sales by Country (2015-2020) Figure Asia-Pacific Parkinson Disease Drug Sales Market Share by Country (2015-2020) Table Asia-Pacific Parkinson Disease Drug Revenue by Country (2015-2020) Figure Asia-Pacific Parkinson Disease Drug Revenue Market Share by Country (2015-2020) Figure Asia-Pacific Parkinson Disease Drug Market Share by Type in 2020 Figure Asia-Pacific Parkinson Disease Drug Market Share by Application in 2020 Figure China Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure China Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Figure Japan Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure Japan Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Figure Korea Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure Korea Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Figure India Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure India Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Figure Southeast Asia Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure Southeast Asia Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Figure Australia Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure Australia Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Table South America Parkinson Disease Drug Sales by Country (2015-2020) Figure South America Parkinson Disease Drug Sales Market Share by Country (2015-2020) Table South America Parkinson Disease Drug Revenue by Country (2015-2020) Figure South America Parkinson Disease Drug Revenue Market Share by Country (2015-2020) Figure South America Parkinson Disease Drug Market Share by Type in 2020 Figure South America Parkinson Disease Drug Market Share by Application in 2020 Figure Brazil Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure Brazil Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Figure Argentina Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure Argentina Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Figure Colombia Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure Colombia Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Table Middle East & Africa Parkinson Disease Drug Sales by Country (2015-2020) Figure Middle East & Africa Parkinson Disease Drug Sales Market Share by Country (2015-2020) Table Middle East & Africa Parkinson Disease Drug Revenue by Country (2015-2020) Figure Middle East & Africa Parkinson Disease Drug Revenue Market Share by Country (2015-2020) Figure Middle East & Africa Parkinson Disease Drug Market Share by Type in 2020 Figure Middle East & Africa Parkinson Disease Drug Market Share by Application in 2020 Figure UAE Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure UAE Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Figure Saudi Arabia Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure Saudi Arabia Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Figure South Africa Parkinson Disease Drug Sales and Growth Rate (2015-2020) Figure South Africa Parkinson Disease Drug Revenue (Million $) and Growth Rate (2015-2020) Table Company Snapshot of Merck Table Parkinson Disease Drug Introduction of Merck Table Parkinson Disease Drug Sales, Price, Revenue, Gross Margin and Market Share of Merck (2018-2020) Table Industrial Chain of Parkinson Disease Drug Table Manufacturing Cost Structure of Parkinson Disease Drug Table General Manufacturing Process of Parkinson Disease Drug Table Leading Distributors/Dealers of Parkinson Disease Drug Table Leading Consumers of Parkinson Disease Drug Figure Global Parkinson Disease Drug Sales and Growth Rate Forecast (2021-2030) Figure Global Parkinson Disease Drug Revenue and Growth Rate Forecast (2021-2030) Table Global Parkinson Disease Drug Market Size and CAGR Forecast by Region (2021-2030) Table Global Parkinson Disease Drug Market Size and CAGR Forecast by Type (2021-2030) Table Global Parkinson Disease Drug Market Size and CAGR Forecast by Application (2021-2030) Table Global Parkinson Disease Drug Market Size and CAGR Forecast by Sales Channel (2021-2030)

Purchase Report

Single User 2500
Multi User 5000
Corporate User 5000
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.